Targeted scoring criteria reduce variance in global impressions

Human Psychopharmacology

Volumn 23, Issue 7, 2008, Pages 629-633

  Targum, Steven D ^a,b,e   Busner, Joan ^c   Young, Allan H ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BrainCells Inc   (United States)

^c UNITED BIOSOURCE CORPORATION   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e NONE   (United States)

Author keywords

CGI; CNS trial; Depressive disorder; Scoring criteria

Indexed keywords

ANXIETY DISORDER; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; DEPRESSION; GASTROINTESTINAL SYMPTOM; HUMAN; INTERRATER RELIABILITY; PRIORITY JOURNAL; REFERENCE VALUE; SCORING SYSTEM; SYMPTOMATOLOGY; VARIANCE;

ANXIETY; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER; HUMANS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 57149129046     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.966     Document Type: Article

References (15)

1. American Psychiatric Association. 2000. Diagnostic and Statistical Manual for Mental Disorders, 3rd edn, revised (DSM-IV-R). American Psychiatric Association: Washington DC.
2. Beneke M, Rasmus W. 1992. Clinical global impressions (ECDEU): some critical comments. Pharmacopsychiatry 25: 171-176.
3. Burke MJ, Finkelstein LM, Dusig MS. 1999. On average deviation indices for estimating interrater agreement. Org Res Method 2(1): 49-68.
4. Busner J, Targum SD. 2007. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry 4(7): 28-37.
5. Fava M, Alpert JE, Carmin CN, et al. 2004. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med 34: 1299-1308.
6. Fava M, Rush J, Alpert JE, et al. 2008. Do outpatients with anxious vs. non-anxious major depressive disorder have different treatment outcomes? A STAR*D report. Am J Psychiatry 168: 342-351.
7. Guy W (ed.). 1976. Clinical global impressions. In ECDEU Assessment Manual for Psychopharmacology, revised, (DHEW Publ No ADM 76-338). National Institute of Mental Health: Rockville, MD; 218-222.
8. Haro JM, Kamath SA, Ochoa S, et al. 2003. The clinical global impression-schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand 107(Suppl 416): 16-23.
9. Kadouri A, Corruble E, Falissard B. 2007. The improved clinical global impression scale (iCGI): development and validation in depression. BMC Psychiatry 7: 1-7.
10. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. 1996. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US national comorbidity survey. Br J Psychiatry 168(Suppl 30): 17-30.
11. Maj M. 2005. Psychiatric comorbidity: an artifact of current diagnostic systems? Br J Psychiatry 186: 182-184.
12. Spearing M, Post RM, Leverich GS, Brandt D, Nolen W. 1997. Modification of the clinical global impression (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 73: 159-171.
13. Spielmans GI, McFall JP. 2006. A comparative meta-analysis of clinical global impressions change in antidepressant trials. J Nerv Ment Dis 194(11): 845-852.
14. Targum SD, Pollack MH, Fava M. 2008. Re-defining affective disorders: relevance for drug development. CNS Neurosci Ther 14: 2-9.
15. Targum SD, Busner J, Dunn J. 2008. Confounding influence of extraneous symptoms on CGI ratings for depression. J Clin Psychopharmacol (in press).